Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
NCT03998202 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2026-01-08
Summary
This study will examine the association between low muscle mass (myopenia) at diagnosis and chemotherapy toxicity in older adults with newly diagnosed advanced colorectal cancer.
Conditions
Sponsors & Collaborators
-
University of Alabama at Birmingham
collaborator OTHER -
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Glenn Lesser, MD · WFUSM
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-23
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
Predictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on Gastric Cancer Patients
NCT06606912 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Preoperative Chemoradiotherapy on Exercise Capacity as Measured by Cardiopulmonary Exercise Testing
NCT00833508 ·Status: COMPLETED ·Phase: NA
-
Predictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on Colorectal Cancer Patients
NCT06614699 ·Status: ACTIVE_NOT_RECRUITING
-
A Longitudinal Study of Cancer-related Fatigue Among Colorectal Cancer Patients During Adjuvant Chemotherapy
NCT03013972 ·Status: UNKNOWN
-
Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer
NCT02882269 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Effect of Cancer Therapies and Exercise on Mitochondrial Energetics and Fitness
NCT01859442 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Function of PA, RBP and TRSF in Malnutrition Detecting and Nutritional Status Monitoring for NPC Patients
NCT03240835 ·Status: COMPLETED
-
Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment
NCT03516942 ·Status: ACTIVE_NOT_RECRUITING
-
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
NCT04755907 ·Status: UNKNOWN
-
Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRC
NCT02893540 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator
NCT05338866 ·Status: ENROLLING_BY_INVITATION
-
Organ Preservation Strategy of Total Neoadjuvant Chemoradiotherapy for Low Rectal Carcinoma
NCT05563922 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy
NCT03071198 ·Status: UNKNOWN ·Phase: NA
-
Mix Vaccine for Metastatic Colorectal Cancer
NCT03357276 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tumor Response Prediction in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer Using Metabonomics Analysis
NCT03149978 ·Status: UNKNOWN
-
Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis
NCT02912052 ·Status: UNKNOWN ·Phase: PHASE3
-
Microbiome and Rectal Cancer
NCT04223102 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
NCT06802172 ·Status: RECRUITING ·Phase: NA
-
CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients
NCT04917289 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
The Value of ctDNA on Chemotherapy Efficacy for mCRC
NCT04555369 ·Status: UNKNOWN ·Phase: NA
-
Oligometastases of the LIVer Treated With Chemotherapy With ou Without Extracranial Stereotactic Body Radiation Therapy in Patients With Colorectal Cancer
NCT03532204 ·Status: WITHDRAWN ·Phase: NA
-
MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer
NCT04790227 ·Status: UNKNOWN
-
A Prospective Multicentre Clinical Study of Dynamic Monitoring of Plasma ctDNA Methylation Markers to Predict Recurrence of Colorectal Cancer After Complete Resection of Peritoneal Metastases
NCT06903325 ·Status: RECRUITING
-
Application of MRI in Identifying Myelosuppression Risk of Neoadjuvant Chemoradiotherapy for Rectal Cancer
NCT04970498 ·Status: UNKNOWN
-
Prehabilitation During Neoadjuvant Chemoradiotherapy for Rectal Cancer
NCT06542354 ·Status: COMPLETED ·Phase: NA